ArticleCardiovascular diabetology. Endocrinology reports2026
The association between obesity and telomere shortening is mediated through total bilirubin.
Article in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBoth obesity and oxidative stress are closely linked to leukocyte telomere length (LTL) shortening, yet the specific mediating role of total bilirubin in this association remains insufficiently explored. This study aimed to quantify the extent to which total bilirubin, a potent endogenous antioxidant, mediates the association between obesity and LTL.
methodsWe analyzed data from 6,717 adults participating in the National Health and Nutrition Examination Survey 1999-2002. Causal mediation analysis with 1,000 bootstrap iterations was employed to investigate the mediating effect of serum total bilirubin on the association between body mass index (BMI) and LTL.
resultsIn the fully adjusted model, BMI was significantly and inversely associated with LTL, with a total effect of -3.532 base pairs (bp) per 1-unit increase in BMI (95% confidence interval [CI]: -6.225 to -1.178; P = 0.002). Serum total bilirubin significantly mediated this association (average causal mediation effect = -0.446 bp; 95% CI: -0.726 to -0.237; P < 0.001). The estimated proportion of the association explained by bilirubin was 13.2% (95% CI: 5.5% to 41.2%; P = 0.002). A series of sensitivity analyses confirmed the robustness and stability of these mediation findings.
conclusionsTotal bilirubin serves as a significant statistical mediator in the relationship between obesity and LTL shortening. However, given the cross-sectional design of this study, further longitudinal investigations are required to confirm these associations and establish causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.